LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1440
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models ; volume:91 ; number:4 ; day:27 ; month:11 ; year:2012 ; pages:513-522 ; date:4.2013
Journal of molecular medicine ; 91, Heft 4 (27.11.2012), 513-522, 4.2013
- Creator
-
Guerreiro, Patrícia Silva
Huang, Yue
Gysbers, Amanda
Cheng, Danni
Gai, Wei Ping
Outeiro, Tiago Fleming
Halliday, Glenda Margaret
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00109-012-0984-y
- URN
-
urn:nbn:de:101:1-2019101009172559729859
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guerreiro, Patrícia Silva
- Huang, Yue
- Gysbers, Amanda
- Cheng, Danni
- Gai, Wei Ping
- Outeiro, Tiago Fleming
- Halliday, Glenda Margaret
- SpringerLink (Online service)
Other Objects (12)
Does A Child Quantity-Quality Trade-Off Exist? Evidence from the One-Child Policy in China
Family Size and Children’s Education: Evidence from the One-Child Policy in China
Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-up
Models of α-synuclein aggregation in Parkinson’s disease
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Does A Child Quantity-Quality Trade-Off Exist? Evidence from the One-Child Policy in China
Family Size and Children’s Education: Evidence from the One-Child Policy in China
Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-up
Models of α-synuclein aggregation in Parkinson’s disease
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Does A Child Quantity-Quality Trade-Off Exist? Evidence from the One-Child Policy in China
Family Size and Children’s Education: Evidence from the One-Child Policy in China
Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-up
Models of α-synuclein aggregation in Parkinson’s disease
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease